RETATRUTIDE 20mg
Higher dose Retatrutide for extended research protocols. Triple GLP-1/GIP/Glucagon agonist — the leading compound in next-generation metabolic dysfunction research.
Product specifications
| Product | RETATRUTIDE |
| Quantity | 20mg |
| Format | Lyophilised Powder |
| Listed purity | ≥98% |
| Storage | Store at -20°C. Reconstituted: 2–8°C, use within 14 days. |
Research information
Ideal for longer duration studies requiring higher concentration. Same triple agonist mechanism as 10mg formulation, supplied as lyophilised powder for reconstitution.
Research use only.
This product is supplied strictly for legitimate scientific research and is not intended for human or veterinary consumption. Product information is not medical advice and should not be interpreted as a recommendation for use in people or animals.
This product is supplied strictly for legitimate scientific research and is not intended for human or veterinary consumption. Product information is not medical advice and should not be interpreted as a recommendation for use in people or animals.